Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
AbstractBone void fillers (BVFs) containing calcium sulfate, tricalcium phosphate (TCP), and hydroxyapatite can be loaded with antibiotics for infection treatment or prevention under surgeon-directed use. The aim of this study was to characterize the handling and elution properties of a triphasic BVF loaded with common antibiotics. BVF was mixed with vancomycin and/or tobramycin to form pellets, and the set time was recorded. A partial refreshment elution study was conducted with time points at 4, 8, and 24 h, as well as 2, 7, 14, 28, and 42 days. Effects on dissolution were evaluated in a 14-day dissolution study. Set time increased to over 1 h for groups containing tobramycin, although vancomycin had a minimal effect. Pellets continued to elute antibiotics throughout the 42-day elution study, suggesting efficacy for the treatment or prevention of orthopedic infections. BVF containing vancomycin or tobramycin showed similar dissolution at 14 days compared to BVF without antibiotics; however, BVF containing both antibiotics showed significantly more dissolution. View Full-Text
Share & Cite This Article
Harris, M.; Ahmed, H.; Pace, L.; Minter, J.; Neel, M.; Jennings, J. Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro. J. Funct. Biomater. 2018, 9, 55.
Harris M, Ahmed H, Pace L, Minter J, Neel M, Jennings J. Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro. Journal of Functional Biomaterials. 2018; 9(4):55.Chicago/Turabian Style
Harris, Michael; Ahmed, Hamza; Pace, Leslie; Minter, Jon; Neel, Michael; Jennings, Jessica. 2018. "Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro." J. Funct. Biomater. 9, no. 4: 55.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.